Cargando…
Smoking and risk of negative outcomes among COVID-19 patients: A systematic review and meta-analysis
INTRODUCTION: COVID-19 has major effects on the clinical, humanistic and economic outcomes among patients, producing severe symptoms and death. Smoking has been reported as one of the factors that increases severity and mortality rate among COVID-19 patients. However, the effect of smoking on such m...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID)
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857247/ https://www.ncbi.nlm.nih.gov/pubmed/33551713 http://dx.doi.org/10.18332/tid/132411 |
_version_ | 1783646407687667712 |
---|---|
author | Umnuaypornlert, Adinat Kanchanasurakit, Sukrit Lucero-Prisno, Don Eliseo III Saokaew, Surasak |
author_facet | Umnuaypornlert, Adinat Kanchanasurakit, Sukrit Lucero-Prisno, Don Eliseo III Saokaew, Surasak |
author_sort | Umnuaypornlert, Adinat |
collection | PubMed |
description | INTRODUCTION: COVID-19 has major effects on the clinical, humanistic and economic outcomes among patients, producing severe symptoms and death. Smoking has been reported as one of the factors that increases severity and mortality rate among COVID-19 patients. However, the effect of smoking on such medical outcomes is still controversial. This study conducted a comprehensive systematic review and meta-analysis (SR/MA) on the association between smoking and negative outcomes among COVID-19 patients. METHODS: Electronic databases, including PubMed, EMBASE, Cochrane Library, Science Direct, Google Scholar, were systematically searched from the initiation of the database until 12 December 2020. All relevant studies about smoking and COVID-19 were screened using a set of inclusion and exclusion criteria. The Newcastle–Ottawa Scale was used to assess the methodological quality of eligible articles. Random meta-analyses were conducted to estimate odds ratios (ORs) with 95% confidence interval (CIs). Publication bias was assessed using the funnel plot, Begg’s test and Egger’s test. RESULTS: A total of 1248 studies were retrieved and reviewed. A total of 40 studies were finally included for meta-analysis. Both current smoking and former smoking significantly increase the risk of disease severity (OR=1.58; 95% CI: 1.16–2.15, p=0.004; and OR=2.48; 95% CI: 1.64–3.77, p<0.001; respectively) with moderate appearance of heterogeneity. Similarly, current smoking and former smoking also significantly increase the risk of death (OR=1.35; 95% CI: 1.12–1.62, p=0.002; and OR=2.58; 95% CI: 2.15–3.09, p<0.001; respectively) with moderate appearance of heterogeneity. There was no evidence of publication bias, which was tested by the funnel plot, Begg’s test and Egger’s test. CONCLUSIONS: Smoking, even current smoking or former smoking, significantly increases the risk of COVID-19 severity and death. Further causational studies on this association and ascertianing the underlying mechanisms of this relation is warranted. |
format | Online Article Text |
id | pubmed-7857247 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID) |
record_format | MEDLINE/PubMed |
spelling | pubmed-78572472021-02-04 Smoking and risk of negative outcomes among COVID-19 patients: A systematic review and meta-analysis Umnuaypornlert, Adinat Kanchanasurakit, Sukrit Lucero-Prisno, Don Eliseo III Saokaew, Surasak Tob Induc Dis Research Paper INTRODUCTION: COVID-19 has major effects on the clinical, humanistic and economic outcomes among patients, producing severe symptoms and death. Smoking has been reported as one of the factors that increases severity and mortality rate among COVID-19 patients. However, the effect of smoking on such medical outcomes is still controversial. This study conducted a comprehensive systematic review and meta-analysis (SR/MA) on the association between smoking and negative outcomes among COVID-19 patients. METHODS: Electronic databases, including PubMed, EMBASE, Cochrane Library, Science Direct, Google Scholar, were systematically searched from the initiation of the database until 12 December 2020. All relevant studies about smoking and COVID-19 were screened using a set of inclusion and exclusion criteria. The Newcastle–Ottawa Scale was used to assess the methodological quality of eligible articles. Random meta-analyses were conducted to estimate odds ratios (ORs) with 95% confidence interval (CIs). Publication bias was assessed using the funnel plot, Begg’s test and Egger’s test. RESULTS: A total of 1248 studies were retrieved and reviewed. A total of 40 studies were finally included for meta-analysis. Both current smoking and former smoking significantly increase the risk of disease severity (OR=1.58; 95% CI: 1.16–2.15, p=0.004; and OR=2.48; 95% CI: 1.64–3.77, p<0.001; respectively) with moderate appearance of heterogeneity. Similarly, current smoking and former smoking also significantly increase the risk of death (OR=1.35; 95% CI: 1.12–1.62, p=0.002; and OR=2.58; 95% CI: 2.15–3.09, p<0.001; respectively) with moderate appearance of heterogeneity. There was no evidence of publication bias, which was tested by the funnel plot, Begg’s test and Egger’s test. CONCLUSIONS: Smoking, even current smoking or former smoking, significantly increases the risk of COVID-19 severity and death. Further causational studies on this association and ascertianing the underlying mechanisms of this relation is warranted. European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID) 2021-02-04 /pmc/articles/PMC7857247/ /pubmed/33551713 http://dx.doi.org/10.18332/tid/132411 Text en © 2021 Umnuaypornlert A. et al. https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License. |
spellingShingle | Research Paper Umnuaypornlert, Adinat Kanchanasurakit, Sukrit Lucero-Prisno, Don Eliseo III Saokaew, Surasak Smoking and risk of negative outcomes among COVID-19 patients: A systematic review and meta-analysis |
title | Smoking and risk of negative outcomes among COVID-19 patients: A systematic review and meta-analysis |
title_full | Smoking and risk of negative outcomes among COVID-19 patients: A systematic review and meta-analysis |
title_fullStr | Smoking and risk of negative outcomes among COVID-19 patients: A systematic review and meta-analysis |
title_full_unstemmed | Smoking and risk of negative outcomes among COVID-19 patients: A systematic review and meta-analysis |
title_short | Smoking and risk of negative outcomes among COVID-19 patients: A systematic review and meta-analysis |
title_sort | smoking and risk of negative outcomes among covid-19 patients: a systematic review and meta-analysis |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857247/ https://www.ncbi.nlm.nih.gov/pubmed/33551713 http://dx.doi.org/10.18332/tid/132411 |
work_keys_str_mv | AT umnuaypornlertadinat smokingandriskofnegativeoutcomesamongcovid19patientsasystematicreviewandmetaanalysis AT kanchanasurakitsukrit smokingandriskofnegativeoutcomesamongcovid19patientsasystematicreviewandmetaanalysis AT luceroprisnodoneliseoiii smokingandriskofnegativeoutcomesamongcovid19patientsasystematicreviewandmetaanalysis AT saokaewsurasak smokingandriskofnegativeoutcomesamongcovid19patientsasystematicreviewandmetaanalysis |